Skip to main content

HELP · Helus Pharma Inc. · Debt

Track HELP — free
$10.52 +0.16 (+1.54%) At close · Oct 27 Q2 2026 earnings call transcript
Market Cap
$757.00M
Shares
73.07M
Volume · Oct 27 1.53M Avg daily vol (3M) 1.71M

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Lease liabilities 2025-03-31 CAD 0 40-F filed 2025-07-01
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current lease liabilities
CAD 0
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1833141 CUSIP 23256X407 13F (30d) 13 filings 13 filers Visit website Investor relations